Endothelial dysfunction and its role in diabetic vascular disease

Endocrinol Metab Clin North Am. 2006 Sep;35(3):551-60, viii-ix. doi: 10.1016/j.ecl.2006.06.006.

Abstract

When normal endothelial function is shifted to a pathological degree, the foundation is laid for possibly following diseases. This endothelial dysfunction is characterized by a proinflammatory state, reduced vasodilation, and a prothrombotic state. In the continuation this dysfunction is strongly associated cardiovascular morbidity and mortality. Endothelial dysfunction is markedly enhanced in type 2 diabetes providing a major pathophysiological cause for the massively increased cardiovascular risk of diabetic patients. Subsequently future therapeutic approaches for the treatment of diabetic cardiovascular disease should target the dysfunctional endothelium first.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / etiology
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetic Angiopathies / etiology
  • Diabetic Angiopathies / physiopathology*
  • Endothelium, Vascular / physiopathology*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Inflammation / complications
  • Inflammation / physiopathology
  • Nitric Oxide / physiology
  • Obesity / complications
  • Obesity / physiopathology
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Nitric Oxide
  • 2,4-thiazolidinedione